Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial | Nature Medicine
Glucose Meters | AgaMatrix
About | Waveform
Oregon medical device maker raises $56M - Portland Business Journal
Glucose Meters | AgaMatrix
AgaMatrix & WaveForm Complete $56 Million Capital Raise
AgaMatrix Announces Reorganization, and Formation of WaveForm Technologies Inc.
Federal Judge Awards AgaMatrix While Admonishing Dexcom
Bayer, WaveForm in tie-up for glucose monitoring solutions for China - Chinadaily.com.cn
Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial | Nature Medicine
Biosensor market to double to $40 billion by 2026 | Fierce Electronics
Artificial Pancreas' Best in Poorly Controlled Type 1 Diabetes
With $32M loan, connected glucometer pioneer AgaMatrix will split company into CGM, BGM businesses | MobiHealthNews
AgaMatrix | Innovative Products for Diabetes Care
With $32M loan, connected glucometer pioneer AgaMatrix will split company into CGM, BGM businesses | MobiHealthNews
Glucose Meters | AgaMatrix
Reorganization, and Formation of WaveForm Technologies Inc.
Wavesense Presto - Agamatrix - 8000-03329 - Blood Glucose Test Strips | StomaBags.com
WaveForm Gets Favorable Decision on Glucose Monitoring Patents
Comparison of Automated Insulin Delivery Systems - Diabetesnet.com
Diabetes Technology Society
Opportunities and challenges in closed-loop systems in type 1 diabetes - The Lancet Diabetes & Endocrinology
AgaMatrix | Innovative Products for Diabetes Care
